Company Filing History:
Years Active: 2018
Title: Innovations by Wei-Jen Cheng in Bone Graft Technology
Introduction
Wei-Jen Cheng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the development of bone graft materials. His innovative approach focuses on enhancing the properties of bone grafts to improve their effectiveness in medical applications.
Latest Patents
Wei-Jen Cheng holds a patent for a method of producing alpha-calcium sulfate hemihydrate bone graft. This invention outlines a process that involves mixing calcium sulfate dihydrate with deionized water to create a paste. The paste is then stirred and heated at a temperature of at least 160°C under pressure conditions of 100-350 psi. This process results in the conversion of calcium sulfate dihydrate into calcium sulfate hemihydrate. The final product is a high-purity bone graft that exhibits excellent mechanical strength and biocompatibility, promoting bone growth and angiogenesis. Notably, the curing process requires a maximum temperature of only 31°C, making it safer for biomedical applications.
Career Highlights
Wei-Jen Cheng is associated with 3D Global Biotech Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of bone graft technology, contributing to innovations that enhance patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Keng-Liang Ou and Chih-Hua Yu, to further his research initiatives and explore new avenues in biomedical applications.
Conclusion
Wei-Jen Cheng's innovative methods in producing alpha-calcium sulfate hemihydrate bone grafts represent a significant advancement in the field of biomedical engineering. His contributions are paving the way for safer and more effective solutions in bone grafting procedures.